SHILPAMED.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Stats
Dagens volum	448 064
Gjennomsnittsvolum	941 192
Markedsverdi	52.46B
EPS	INR0 ( 2024-02-12 )
Neste inntjeningsdato	( INR0 ) 2024-05-23
Last Dividend	INR1.100 ( 2022-09-19 )
Next Dividend	INR0 ( N/A )
P/E	-10 730
ATR14	INR0.544 (0.10%)

Volum Korrelasjon

Lang: -0.02 (neutral)

Kort: -0.44 (neutral)

Signal:(37.423) Neutral

Shilpa Medicare Limited Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Shilpa Medicare Limited Korrelasjon - Valuta/Råvare

-0.01
( neutral )

0.57
( weak )

0.53
( weak )

-0.70
( moderate negative )

0.35
( neutral )

-0.30
( neutral )

Shilpa Medicare Limited Økonomi

Annual	2022
Omsetning:	INR10.50B
Bruttogevinst:	INR6.34B (60.39 %)
EPS:	INR-3.74

FY	2022
Omsetning:	INR10.50B
Bruttogevinst:	INR6.34B (60.39 %)
EPS:	INR-3.74

FY	2022
Omsetning:	INR11.40B
Bruttogevinst:	INR7.56B (66.31 %)
EPS:	INR7.26

FY	2021
Omsetning:	INR9.00B
Bruttogevinst:	INR6.29B (69.92 %)
EPS:	INR18.13

Financial Reports:

No articles found.

Shilpa Medicare Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR1.100 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Shilpa Medicare Limited Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.233	2010-09-16
Last Dividend	INR1.100	2022-09-19
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	13	--
Total Paid Out	INR8.48	--
Avg. Dividend % Per Year	0.10%	--
Score	0.67	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-14)

INR0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

0.67

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0.700	0.15%
2019	INR1.000	0.26%
2020	INR1.100	0.39%
2021	INR1.100	0.25%
2022	INR1.100	0.19%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUTLEJTEX.NS	Dividend Junior	2023-08-18	Annually	18	1.03%
NDRAUTO.NS	Dividend Junior	2023-07-12	Annually	4	0.59%
ICICIGI.NS	Dividend Junior	2023-06-12	Annually	8	0.36%
CENTENKA.NS	Dividend Junior	2023-08-11	Annually	22	1.85%
RUBYMILLS.NS	Dividend Junior	2023-09-20	Annually	23	0.96%
LINCOLN.NS	Dividend Junior	2023-09-15	Annually	9	0.32%
GEECEE.NS	Dividend Junior	2023-09-08	Sporadic	18	0.97%
ARIHANTCAP.NS	Dividend Junior	2023-07-28	Annually	4	0.39%
TEXINFRA.NS	Dividend Junior	2023-09-18	Annually	20	0.18%
OPTIEMUS.NS	Dividend Junior	2023-06-07	Insufficient data to determine frequency	2	0.16%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.000597	1.500	-0.0119	-0.0179	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.000377	1.500	-1.115	-1.673	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	1.259	1.000	-0.645	-0.645	[3 - 30]
operatingCashFlowPerShareTTM	24.64	2.00	1.787	3.57	[0 - 30]
freeCashFlowPerShareTTM	24.64	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.644	1.000	2.60	2.60	[0.2 - 0.8]
operatingProfitMarginTTM	0.0957	1.000	-0.0864	-0.0864	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.346

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-7 014.56	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.000377	2.50	-0.717	-1.673	[0.1 - 1.5]
freeCashFlowPerShareTTM	24.64	2.00	1.787	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	24.64	2.00	1.787	3.57	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-637.24	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.190	1.000	7.74	0	[0.1 - 0.5]
Total Score				-0.690

Shilpa Medicare Limited

Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.